会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 51. 发明授权
    • Methods and compositions for the treatment of gastrointestinal disorders
    • 用于治疗胃肠道疾病的方法和组合物
    • US07304036B2
    • 2007-12-04
    • US10796719
    • 2004-03-09
    • Mark G. CurrieShalina Mahajan-MiklosThea NormanG. Todd Milne
    • Mark G. CurrieShalina Mahajan-MiklosThea NormanG. Todd Milne
    • C07K7/08
    • C07K7/08C07K14/245
    • The present invention features compositions and related methods for treating IBS and other gastrointestinal disorders and conditions (e.g., gastrointestinal motility disorders, functional gastrointestinal disorders, gastroesophageal reflux disease (GERD), Crohn's disease, ulcerative colitis, Inflammatory bowel disease, functional heartburn, dyspepsia (including functional dyspepsia or nonulcer dyspepsia), gastroparesis, chronic intestinal pseudo-obstruction (or colonic pseudo-obstruction), and disorders and conditions associated with constipation, e.g., constipation associated with use of opiate pain killers, post-surgical constipation (post-operative ileus), and constipation associated with neuropathic disorders as well as other conditions and disorders using peptides and other agents that activate the guanylate cyclase C (GC-C) receptor.
    • 本发明的特征在于用于治疗IBS和其他胃肠道疾病和病症(例如胃肠蠕动障碍,功能性胃肠道疾病,胃食管反流病(GERD),克罗恩病,溃疡性结肠炎,炎性肠病,功能性胃灼热,消化不良( 包括功能性消化不良或非溃疡性消化不良),胃轻瘫,慢性肠假性梗阻(或结肠假性梗阻)以及与便秘相关的疾病和病症,例如与使用阿片类止痛药相关的便秘,手术后便秘 肠梗阻)和与神经性疾病相关的便秘以及使用活化鸟苷酸环化酶C(GC-C)受体的肽和其它试剂的其他病症和病症。
    • 54. 发明授权
    • Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
    • 含有,涉及非天然氨基酸和多肽的方法和使用的组合物
    • US08865658B2
    • 2014-10-21
    • US13467870
    • 2012-05-09
    • Zhenwei MiaoJunjie LiuThea Norman
    • Zhenwei MiaoJunjie LiuThea Norman
    • C07K2/00C07K7/00A61K38/04A61K38/18C07K1/00C07C229/42
    • C07K2/00C07C229/42C07K1/006
    • Disclosed herein are non-natural amino acids and polypeptides that include at least one non-natural amino acid, and methods for making such non-natural amino acids and polypeptides. The non-natural amino acids, by themselves or as a part of a polypeptide, can include a wide range of possible functionalities, but typical have at least one aromatic amine group. Also disclosed herein are non-natural amino acid polypeptides that are further modified post-translationally, methods for effecting such modifications, and methods for purifying such polypeptides. Typically, the modified non-natural amino acid polypeptides include at least one alkylated amine group. Further disclosed are methods for using such non-natural amino acid polypeptides and modified non-natural amino acid polypeptides, including therapeutic, diagnostic, and other biotechnology uses.
    • 本文公开了包含至少一种非天然氨基酸的非天然氨基酸和多肽,以及制备这种非天然氨基酸和多肽的方法。 非天然氨基酸本身或作为多肽的一部分可以包括广泛范围的可能的官能团,但典型地具有至少一个芳族胺基团。 本文还公开了在翻译后进一步修饰的非天然氨基酸多肽,用于实现这种修饰的方法,以及纯化这些多肽的方法。 通常,修饰的非天然氨基酸多肽包括至少一个烷基化胺基团。 进一步披露的是使用这种非天然氨基酸多肽和修饰的非天然氨基酸多肽的方法,包括治疗,诊断和其他生物技术用途。
    • 58. 发明授权
    • Methods and compositions for the treatment of gastrointestinal disorders
    • 用于治疗胃肠道疾病的方法和组合物
    • US07745409B2
    • 2010-06-29
    • US11949340
    • 2007-12-03
    • Mark G. CurrieShalina Mahajan-MiklosThea NormanG. Todd Milne
    • Mark G. CurrieShalina Mahajan-MiklosThea NormanG. Todd Milne
    • A61K38/00
    • C07K7/08C07K14/245
    • The present invention features compositions and related methods for treating IBS and other gastrointestinal disorders and conditions (e.g., gastrointestinal motility disorders, functional gastrointestinal disorders, gastroesophageal reflux disease (GERD), Crohn's disease, ulcerative colitis, Inflammatory bowel disease, functional heartburn, dyspepsia (including functional dyspepsia or nonulcer dyspepsia), gastroparesis, chronic intestinal pseudo-obstruction (or colonic pseudo-obstruction), and disorders and conditions associated with constipation, e.g., constipation associated with use of opiate pain killers, post-surgical constipation (post-operative ileus), and constipation associated with neuropathic disorders as well as other conditions and disorders using peptides and other agents that activate the guanylate cyclase C (GC-C) receptor.
    • 本发明的特征在于用于治疗IBS和其他胃肠道疾病和病症(例如胃肠蠕动障碍,功能性胃肠道疾病,胃食管反流病(GERD),克罗恩病,溃疡性结肠炎,炎性肠病,功能性胃灼热,消化不良( 包括功能性消化不良或非溃疡性消化不良),胃轻瘫,慢性肠假性梗阻(或结肠假性梗阻)以及与便秘相关的疾病和病症,例如与使用阿片类止痛药相关的便秘,手术后便秘 肠梗阻)和与神经性疾病相关的便秘以及使用活化鸟苷酸环化酶C(GC-C)受体的肽和其它试剂的其他病症和病症。